Intracerebroventricular administration of oxytocin and intranasal administration of the oxytocin derivative improve β‐amyloid peptide (25–35)‐induced memory impairment in mice - Takahashi, Junpei; Ueta, Yudai; Yamada, Daisuke; Sasaki‐Hamada, Sachie; Iwai, Takashi; Akita, Tomomi; Yamashita, Chikamasa; Saitoh, Akiyoshi; Oka, Jun‐Ichiro (Neuropsychopharmacology reports, 2022)
Keywords: Administration, Intranasal; Alzheimer Disease - chemically induced; Alzheimer Disease - drug therapy; Alzheimer's disease; amnesia; Amyloid beta-Peptides; Animal cognition; Animals; Brain; brain drug delivery and targeting; intranasal administration; Memory; Memory Disorders - chemically induced; Memory Disorders - drug therapy; Mice; oxytocin; Oxytocin - adverse effects; Peptides; spatial memory; β‐amyloid peptide (25–35); Japan; amnesia; oxytocin; β-amyloid peptide (25-35); intranasal administration; spatial memory; brain drug delivery and targeting